Parkinsons Disease Drug Market Report

China Parkinsons Disease Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：149
  • REPORT CODE：GMM1757136
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinsons Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • Valeant

    • Boehringer Ingelheim

    • Stada Arzneimittel

    • Desitin Arzneimittel

    • GSK

    • HLundbeck

    • Astellas Pharma

    • Apokyn

    • Teva Pharmaceutical

    • Abbvie

    • Orion

    • Akorn

    • Endo Pharmaceuticals

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Parkinsons Disease Drug Market Overview 2018-2029

    • 1.1 China Parkinsons Disease Drug Industry Development Overview

    • 1.2 China Parkinsons Disease Drug Industry Development History

    • 1.3 China Parkinsons Disease Drug Industry Market Size (2018-2029)

    • 1.4 China Parkinsons Disease Drug Market Analysis by Type from Production Side

      • 1.4.1 China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Parkinsons Disease Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Parkinsons Disease Drug Market Analysis by Region

      • 1.6.1 North China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Parkinsons Disease Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Parkinsons Disease Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Parkinsons Disease Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Parkinsons Disease Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Parkinsons Disease Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Parkinsons Disease Drug Industry Development

    Chapter 3 Parkinsons Disease DrugIndustry Chain Analysis

    • 3.1 Parkinsons Disease Drug Industry Chain

    • 3.2 Parkinsons Disease Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Parkinsons Disease Drug Market

    • 3.3 Parkinsons Disease Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Parkinsons Disease Drug Market

    Chapter 4 China Parkinsons Disease Drug Market, by Type

    • 4.1 China Parkinsons Disease Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Parkinsons Disease Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Parkinsons Disease Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Parkinsons Disease Drug Production Volume and Growth Rate of Type 1

      • 4.5.2 China Parkinsons Disease Drug Production Volume and Growth Rate of Type 2

      • 4.5.3 China Parkinsons Disease Drug Production Volume and Growth Rate of Type 3

    Chapter 5 China Parkinsons Disease Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Parkinsons Disease Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Parkinsons Disease Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Parkinsons Disease Drug Market Size and Growth Rate of Application 1

      • 5.5.2 China Parkinsons Disease Drug Market Size and Growth Rate of Application 2

      • 5.5.3 China Parkinsons Disease Drug Market Size and Growth Rate of Application 3

    Chapter 6 China Parkinsons Disease Drug Market, by Region

    • 6.1 China Parkinsons Disease Drug Production Volume and Production Value, by Region

    • 6.2 China Parkinsons Disease Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Parkinsons Disease Drug Market Analysis

    • 7.1 North China Parkinsons Disease Drug Market, by Type

    • 7.2 North China Parkinsons Disease Drug Market, by Application

    Chapter 8 Central China Parkinsons Disease Drug Market Analysis

    • 8.1 Central China Parkinsons Disease Drug Market, by Type

    • 8.2 Central China Parkinsons Disease Drug Market, by Application

    Chapter 9 South China Parkinsons Disease Drug Market Analysis

    • 9.1 South China Parkinsons Disease Drug Market, by Type

    • 9.2 South China Parkinsons Disease Drug Market, by Application

    Chapter 10 East China Parkinsons Disease Drug Market Analysis

    • 10.1 East China Parkinsons Disease Drug Market, by Type

    • 10.2 East China Parkinsons Disease Drug Market, by Application

    Chapter 11 Northeast China Parkinsons Disease Drug Market Analysis

    • 11.1 Northeast China Parkinsons Disease Drug Market, by Type

    • 11.2 Northeast China Parkinsons Disease Drug Market, by Application

    Chapter 12 Southwest China Parkinsons Disease Drug Market Analysis

    • 12.1 Southwest China Parkinsons Disease Drug Market, by Type

    • 12.2 Southwest China Parkinsons Disease Drug Market, by Application

    Chapter 13 Northwest China Parkinsons Disease Drug Market Analysis

    • 13.1 Northwest China Parkinsons Disease Drug Market, by Type

    • 13.2 Northwest China Parkinsons Disease Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Parkinsons Disease Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Valeant

        • 14.2.1 Valeant Company Profile

        • 14.2.2 Valeant Parkinsons Disease Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Boehringer Ingelheim

        • 14.3.1 Boehringer Ingelheim Company Profile

        • 14.3.2 Boehringer Ingelheim Parkinsons Disease Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Stada Arzneimittel

        • 14.4.1 Stada Arzneimittel Company Profile

        • 14.4.2 Stada Arzneimittel Parkinsons Disease Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Desitin Arzneimittel

        • 14.5.1 Desitin Arzneimittel Company Profile

        • 14.5.2 Desitin Arzneimittel Parkinsons Disease Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GSK

        • 14.6.1 GSK Company Profile

        • 14.6.2 GSK Parkinsons Disease Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 HLundbeck

        • 14.7.1 HLundbeck Company Profile

        • 14.7.2 HLundbeck Parkinsons Disease Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Astellas Pharma

        • 14.8.1 Astellas Pharma Company Profile

        • 14.8.2 Astellas Pharma Parkinsons Disease Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Apokyn

        • 14.9.1 Apokyn Company Profile

        • 14.9.2 Apokyn Parkinsons Disease Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Teva Pharmaceutical

        • 14.10.1 Teva Pharmaceutical Company Profile

        • 14.10.2 Teva Pharmaceutical Parkinsons Disease Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Abbvie

        • 14.11.1 Abbvie Company Profile

        • 14.11.2 Abbvie Parkinsons Disease Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Orion

        • 14.12.1 Orion Company Profile

        • 14.12.2 Orion Parkinsons Disease Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Akorn

        • 14.13.1 Akorn Company Profile

        • 14.13.2 Akorn Parkinsons Disease Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Endo Pharmaceuticals

        • 14.14.1 Endo Pharmaceuticals Company Profile

        • 14.14.2 Endo Pharmaceuticals Parkinsons Disease Drug Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Parkinsons Disease Drug Industry Research Conclusions

    • 15.2 Parkinsons Disease Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Parkinsons Disease Drug Industry Market Size (2018-2029)

    • Figure China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Parkinsons Disease Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Parkinsons Disease Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Parkinsons Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Parkinsons Disease Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Parkinsons Disease Drug Market Share by Type in 2018

    • Figure China Parkinsons Disease Drug Market Share by Type in 2023

    • Figure China Parkinsons Disease Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Parkinsons Disease Drug Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Parkinsons Disease Drug Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Parkinsons Disease Drug Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Parkinsons Disease Drug Market Share by Application in 2018

    • Figure China Parkinsons Disease Drug Market Share by Application in 2023

    • Figure China Parkinsons Disease Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Parkinsons Disease Drug Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Parkinsons Disease Drug Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Parkinsons Disease Drug Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Parkinsons Disease Drug Production Volume by Region (2018-2023)

    • Table China Parkinsons Disease Drug Production Volume Share by Region (2018-2023)

    • Figure China Parkinsons Disease Drug Production Volume Share by Region (2018-2023)

    • Table China Parkinsons Disease Drug Production Value by Region (2018-2023)

    • Table China Parkinsons Disease Drug Production Value Share by Region (2018-2023)

    • Figure China Parkinsons Disease Drug Production Value Share by Region (2018-2023)

    • Table China Parkinsons Disease Drug Sales Volume by Region (2018-2023)

    • Table China Parkinsons Disease Drug Sales Volume Share by Region (2018-2023)

    • Figure China Parkinsons Disease Drug Sales Volume Share by Region (2018-2023)

    • Table China Parkinsons Disease Drug Sales Value by Region (2018-2023)

    • Table China Parkinsons Disease Drug Sales Value Share by Region (2018-2023)

    • Figure China Parkinsons Disease Drug Sales Value Share by Region (2018-2023)

    • Table North China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table North China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure North China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table North China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table North China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table Central China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table Central China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table Central China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table South China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table South China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure South China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table South China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table South China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table East China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table East China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure East China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table East China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table East China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table Northeast China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table Southwest China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Parkinsons Disease Drug Production Volume by Type (2018-2023)

    • Table Northwest China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Parkinsons Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Parkinsons Disease Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Parkinsons Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Valeant Company Profile

    • Table Valeant Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Stada Arzneimittel Company Profile

    • Table Stada Arzneimittel Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Desitin Arzneimittel Company Profile

    • Table Desitin Arzneimittel Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table HLundbeck Company Profile

    • Table HLundbeck Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Apokyn Company Profile

    • Table Apokyn Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Abbvie Company Profile

    • Table Abbvie Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Orion Company Profile

    • Table Orion Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Akorn Company Profile

    • Table Akorn Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Endo Pharmaceuticals Company Profile

    • Table Endo Pharmaceuticals Parkinsons Disease Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US